Largest Pharmaceuticals companies in Switzerland by Market Capitalization
Switzerland
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 233.77 B |
Jan. 14, 2025 | USD 310.22 | 0.71% |
|
Switzerland |
|
| 2 |
USD 197.34 B |
Jan. 14, 2025 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 3 |
USD 42.45 B |
Jan. 14, 2025 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 4 |
USD 41.01 B |
Jan. 14, 2025 | USD 82.92 | 0.05% |
|
Switzerland |
|
| 5 |
USD 25.92 B |
Jan. 14, 2025 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 6 |
USD 20.70 B |
Jan. 14, 2025 | USD 129.81 | 2.09% |
|
Switzerland |
|
| 7 |
USD 18.51 B |
Jan. 14, 2025 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 8 |
USD 4.85 B |
Jan. 14, 2025 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 9 |
USD 4.80 B |
Jan. 14, 2025 | USD 73.83 | -0.24% |
|
Switzerland |
|
| 10 |
USD 4.57 B |
Jan. 14, 2025 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 11 |
USD 4.52 B |
Jan. 14, 2025 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 12 |
USD 4.20 B |
Jan. 14, 2025 | USD 84.29 | 1.29% |
|
Switzerland |
|
| 13 |
USD 3.27 B |
Jan. 14, 2025 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 14 |
USD 3.17 B |
Jan. 14, 2025 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 15 |
USD 3.14 B |
Jan. 14, 2025 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 16 |
USD 2.93 B |
Jan. 14, 2025 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 17 |
USD 2.39 B |
Jan. 14, 2025 | USD 140.65 | 0.97% |
|
Switzerland |
|
| 18 |
USD 2.38 B |
Jan. 14, 2025 | USD 119.40 | 0.87% |
|
Switzerland |
|
| 19 |
USD 1.84 B |
Jan. 14, 2025 | USD 81.72 | -0.97% |
|
Switzerland |
|
| 20 |
USD 997.82 M |
Jan. 14, 2025 | USD 73.39 | 4.71% |
|
Switzerland |
|
| 21 |
USD 941.25 M |
Jan. 14, 2025 | USD 22.44 | 0.27% |
|
Switzerland |
|
| 22 |
USD 923.14 M |
Jan. 14, 2025 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 23 |
USD 911.45 M |
Jan. 14, 2025 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 24 |
USD 539.74 M |
Jan. 14, 2025 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 25 |
USD 518.05 M |
Jan. 14, 2025 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 26 |
USD 510.93 M |
Jan. 14, 2025 | USD 85.22 | -0.53% |
|
Switzerland |
|
| 27 |
USD 452.17 M |
Jan. 14, 2025 | USD 11.09 | -3.14% |
|
Switzerland |
|
| 28 |
USD 396.98 M |
Jan. 14, 2025 | USD 165.41 | 0.50% |
|
Switzerland |
|
| 29 |
USD 337.76 M |
Jan. 14, 2025 | USD 56.52 | -0.28% |
|
Switzerland |
|
| 30 |
USD 258.24 M |
Jan. 14, 2025 | USD 2.61 | NA |
|
Switzerland |
|
| 31 |
USD 201.90 M |
Jan. 14, 2025 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 32 |
USD 175.58 M |
Jan. 14, 2025 | USD 14.50 | 8.00% |
|
Switzerland |
|
| 33 |
USD 168.45 M |
Jan. 14, 2025 | USD 19.40 | 2.88% |
|
Switzerland |
|
| 34 |
USD 165.34 M |
Jan. 14, 2025 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 35 |
USD 8.27 M |
Jan. 14, 2025 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 36 |
USD 5.60 M |
Jan. 14, 2025 | USD 2.03 | -1.93% |
|
Switzerland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Switzerland has the highest Market Capitalization ?
The Pharmaceuticals company in Switzerland with the highest Market Capitalization is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 233.77 B.
-
Which Pharmaceuticals company in Switzerland has the lowest Market Capitalization ?
The Pharmaceuticals company in Switzerland with the lowest Market Capitalization is NLS Pharmaceutics AG (NasdaqCM: NLSP) at USD 5.60 M.
-
What are the top 10 Pharmaceuticals companies in Switzerland by Market Capitalization ?
The top 10 Pharmaceuticals companies in Switzerland by Market Capitalization are Roche Holding AG, Novartis AG, Lonza Group AG, Alcon Inc., DSM-Firmenich AG, Straumann Holding AG, Sandoz Group AG, Ypsomed Holding AG, DKSH Holding AG and Bachem Holding AG.
-
What are the bottom 10 Pharmaceuticals companies in Switzerland by Market Capitalization ?
The bottom 10 Pharmaceuticals companies in Switzerland by Market Capitalization are NLS Pharmaceutics AG, Addex Therapeutics Ltd, ADC Therapeutics SA, DocMorris AG, Santhera Pharmaceuticals Holding AG, Molecular Partners AG, AC Immune SA, COLTENE Holding AG, IVF Hartmann Holding AG and medmix AG.